miRNAs inhibited genes associated with cancer development or led to the apoptosis of cancer cells; for example, the VV delivered miR-34a, which repressed the anti-apoptotic protein Bcl-2 and promoted the release of cytochrome c in myeloma cells [145]. The gene discussed is BCL2; the disease is cancer.